Latest Breaking News On - John vissing - Page 1 : comparemela.com

Investigational FSHD Drug Did Little to Change DUX4 Expression

Losmapimod was associated with small improvements in fat infiltration, upper arm function

United kingdomUnited statesJohn vissingNicol voermansJohn jiangSophie putkaUniversity of copenhagenRadboud university medical centerFulcrum therapeuticsPatient global impressionWall street journalBusiness insiderCannabis wireMedpage today

Gene therapy for rare muscular dystrophy presents promise

Gene therapy for rare muscular dystrophy presents promise
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomJohn vissingSophie olivierInternational limbDrug administrationEuropean society of gene cell therapyAtamyo therapeuticsEuropean societyCell therapyLimb girdle muscular dystrophyChief medicalData safety monitoring boardInvestigational new drug

Atamyo Therapeutics: First Clinical Results of ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Presented at ESGCT

Atamyo Therapeutics: First Clinical Results of ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Presented at ESGCT
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBruxelles capitaleJohn vissingIsabelle richardIndiens wirtschaftSophie olivierCharles craigNicolai preislerIhre chancenOpus biotech communicationsProgressive muscular dystrophies laboratory at genethonInternational limbEuropean society of gene cell therapyData safety monitoring boardAnnual congress

First Clinical Results of ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Presented at ESGCT

First Clinical Results of ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Presented at ESGCT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBruxelles capitaleIsabelle richardCharles craigNicolai preislerJohn vissingSophie olivierEuropean society of gene cell therapyOpus biotech communicationsProgressive muscular dystrophies laboratory at genethonInternational limbData safety monitoring boardAnnual congressEuropean societyCell therapy

Atamyo Therapeutics Announces participation in Conferences and Key Scientific Communications on its LGMD programs

Atamyo Therapeutics Announces participation in Conferences and Key Scientific Communications on its LGMD programs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBruxelles capitaleStephane degoveE gicquel genethonCharles craigA brureau genethonNicolai preislerJohn vissingInternational annual congressInternational limbJ vissing copenhagen neuromuscular centerProgressive muscular dystrophies laboratory at genethonWorld muscle societyEuropean society of gene cell therapyOpus biotech communications